COVAX supply update on COVID-19 vaccination in Syria, 10 May 2022
Summary
As of 9 May 2022, the total number of COVID-19 vaccines delivered to Syria through the COVAX Facility is 11 347 640 doses, in addition to 2 763 640 doses received through bilateral agreements. The available doses will enable Syria to reach about 45.4% of the population.
Between 23 March and 4 April 2022, 1 043 700 doses of AstraZeneca Covishield reached Syria via COVAX. So far, vaccines received from bilateral agreements represent 20% of the total vaccines received, and the remaining 80% were delivered through COVAX.
The vaccines are administered as part of the ongoing national vaccination campaign across the country.
Vaccination process
Vaccination activities continue across Syria at both fixed health facilities and through mobile medical teams in rural areas.
An increase of 44% in the number of administered doses was observed in April compared to March, due to the intensification of vaccination activities at mosques and shopping centres.
The Ministry of Health made vaccines available not only in designated health centres, but also in places where people visit the most. During the month of Ramadan, the implementation of vaccination during Tarawih prayers was carried out at 468 selected mosques in 6 governorates accompanied by workshops for religious leaders in different governorates. In addition, 13 churches, 2 malls and 2 parks were included in these activities.
Readiness for vaccines
Government and northeast Syria vaccination strategy as per the National Deployment and Vaccination Planto deliver vaccines
1037 fixed health facilities, including 43 hospitals and 994 PHC centres
361 mobile teams to cover rural and hard-to-reach areas
In total: 1398 vaccination teams are deployed (5499 health workers)
Northwest Syria
Increasing COVID-19 vaccination teams from 61 to 100 teams: 60 will work as outreach teams, while the other 40 teams will be located as fixed sites in the most populated areas, such as internally displaced persons camps and different cities in northwest Syria.
Priority groups
As per the National Deployment and Vaccination Plan, the vaccination priority groups include all adults over 18 years of age with special emphasis on health care workers, elderly, and people with comorbidities.
Challenges
The late arrival of vaccines makes it difficult for timely implementation of vaccination putting pressure on an already fragile health system. Overall vaccine hesitancy and the short expiry dates of some vaccine shipments create another challenge in achieving high vaccination rates.
Brussels VI Conference: "Supporting the future of Syria and the region": side event on health and the impact of the socio-economic crisis in Syria

Join the important side event on health and the impact of the socio-economic crisis in Syria to be convened by WHO, in partnership with the Italian Agency for Development Cooperation and the United Nations Development Programme. The event will take place on 6 May, at 10 am Brussels time on the margins of the Brussels VI Conference on Syria.
Watch the event livestreamed on:
Twitter (English): www.twitter.com/WHOEMRO
Facebook (Arabic): www.facebook.com/WHOEMRO
YouTube (French): www.youtube.com/whoemr
Join this important panel discussion with Q&A that will focus on new multilateral partnerships and actions needed now to revitalize Syria’s severely disrupted health care system.
Related link
Syria launches national strategy on reproductive, maternal, neonatal, child and adolescent health

The Ministry of Health of Syria has recently launched its national strategy on reproductive, maternal, neonatal, child and adolescent health, with support from WHO, the United Nations Population Fund and UNICEF. The strategy will contribute to reducing neonatal, child and maternal mortality and enhancing the well-being of women, children and adolescents through comprehensive access to health services.
“Too many women and children are still dying because they lack access to quality health care, resources, and information,” said Dr Akjemal Magtymova, Head of Mission and WHO Representative in Syria.
WHO has been involved in the development of the strategy since its conceptualization and the situation analysis, and will support its implementation through operational planning with an indicators framework and costing. WHO has been supporting the reproductive, maternal, and children’s health in many ways, which include some of the most recent work in 2021, such as:
Integrated Management of Childhood Illnesses programme through 540 health centres that received over 1 million child patient visits in a year.
Nutrition surveillance through 968 health centres that provided over 1 million services and detected 20 000 cases of malnutrition.
Nineteen (19) stabilization centres that treated over 1500 complicated cases of malnutrition.
Infant and young child feeding programme in 761 health centres, providing more than 285 000 services.
Neonatal resuscitation programme in 38 hospitals that offered different interventions to prevent asphyxia in more than 70 000 deliveries.
Youth-friendly centres that provided over 25 000 services.
Newborn care-at-home programme that conducted 20 000 home visits to detect risk signs in pregnant women and newborns and referred them, when needed, to special care.
Capacity of reproductive health professionals built through specialized training courses to 630 midwives.
Development and distribution of reprodcutive guidelines and awareness-raising materials on pre-marital testing, sexually transmitted infections and family planning.
“We all can contribute to the implementation of the strategy, so that mothers can experience safe childbirth, babies are born healthy and develop to their fullest potential from birth to their adolescence and adult life," Dr Akjemal noted.
Story of Muhdia: Health services in Syria support hundreds of TB patients
27 March 2022 - 25-year-old Muhdia from Karm Myasser district in Aleppo, Syria, was diagnosed with tuberculosis (TB) after being examined by the TB mobile clinic. Muhdia was losing weight, coughed frequently, had fever and difficulties in breathing. Thanks to the agility of physicians, she was immediately referred to the TB centre in Aleppo where doctors started the treatment and explained the importance of taking medication for the next two years for the full recovery.
After three months of intensive multiple drug-resistant treatment, Muhdia started recovering. She became pregnant and for the fear of harming an unborn baby, she initially refused to continue the treatment.
“I was panic-stricken at the thought of losing my baby,” said Muhdia.
TB professionals convinced her to maintain the treatment and observe any side effects. The centre also provided follow up services at Muhdia’s home. She has delivered a healthy child and has been continuing her treatment.
“Thanks to the treatment and supportive health professionals, I feel much better, and my baby is healthy. It helped me get through a time of great worry and uncertainty,” Muhdia said.
Since the Aleppo TB centre reopened in 2018, it has admitted many patients. The centre, which is the only health care facility in Aleppo governorate that specializes in treating TB, provides free diagnosis and treatment services to patients from four neighbouring governorates in northern Syria.
The daily operation of the centre and of the mobile clinics is supported by WHO through the contribution of the Global Fund to Fight AIDS, TB and Malaria, while the Government of Japan supported the rehabilitation. TB services, including diagnosis, treatment and awareness sessions, are provided to internally displaced people and other vulnerable populations in emergency response areas, as well as penitentiary facilities since March 2020. Since then, more than 78 606 people throughout the country have benefited from the services of mobile clinics, and 180 TB cases have been diagnosed in Aleppo alone.
In 2021, over 685 people with TB in Aleppo were diagnosed and offered treatment. WHO also helps provide financial aid and food baskets to support TB patients and their families during their treatment journey.
“WHO is committed to facilitate active case-finding to identify people with the disease and give them the help they need,” said Dr Akjemal Magtymova, Head of Mission and WHO Representative in the Syrian Arab Republic. “As low as the TB prevalence in Syria might be, the pre-conditions for contracting TB are quite high. Undernutrition, poverty, HIV, diabetes and tobacco are among the key drivers of the TB epidemic. I believe that with joint efforts elimination of TB is possible,” Dr Akjemal Magtymova added.